ERD

In vitro genotoxicity testing of four reference metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silv...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

report on NanoReg2 - OECD conference on grouping

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Report on Validated grouping approach

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Report on existing Grouping Strategies (NANoREG, OECD, ECHA or others) and available datasets from other projects (e.g. ...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Chapter 6. Health Hazard and Risk Assessment of Nanoparticles Applied in Biomedicine

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Carboxylated nanodiamonds can be used as negative reference in in vitro nanogenotoxicity studies

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

NanoGenotoxicology: present and the future

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Sensitive detection of DNA oxidation damage induced by nanomaterials

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Organisation of a Kick-Off Meeting (All Participants, EC)

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Document on the feasibility to come to organized pre-regulatory safety dossiers

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Final Standardisation plan

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Progress review reports by industrial technical advisors on the overall progress of the project and on progress within e...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

perspectives on how regulations can keep pace with innovation (paper)

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Document describing a blueprint for the creation of trusted environments per stage gate to share information among stake...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Report on integrated safety assessment framework

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Overview of barriers and possible solutions for implementation of the Safe Innovations Approach

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Usefulness of fish cell lines for the initial characterization of toxicity and cellular fate of graphene-related materia...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Drug Delivery Nanosystems for Cardiovascular Stents

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Toxicity evaluation of monodisperse PEGylated magnetic nanoparticles for nanomedicine

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Implementation of Safe-by-Design for Nanomaterial Development and Safe Innovation: Why We Need a Comprehensive Approach

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Nanomedicine and epigenome. Possible health risks

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Implementation manual of the Safe Innovations Approach for all users

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

NANoREG II website

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Towards the development of a high throughput screening approach for Mytilus edulis hemocytes: A case study on silicon-ba...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Refining in vitro models for nanomaterial exposure to cells and tissues

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Fate modelling of nanoparticle releases in LCA: An integrative approach towards “USEtox4Nano”

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Investigating a transcriptomic approach on marine mussel hemocytes exposed to carbon nanofibers: An in vitro/in vivo com...

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

In Vitro Approaches for Assessing the Genotoxicity of Nanomaterials

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?

Project: NanoREG II

Updated at: 29-04-2024

Show more information

Project acronym NanoREG II

Resources

Selected filters:

In vitro genotoxicity testing of four reference metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silv...

report on NanoReg2 - OECD conference on grouping

Report on Validated grouping approach

Report on existing Grouping Strategies (NANoREG, OECD, ECHA or others) and available datasets from other projects (e.g. ...

Chapter 6. Health Hazard and Risk Assessment of Nanoparticles Applied in Biomedicine

Carboxylated nanodiamonds can be used as negative reference in in vitro nanogenotoxicity studies

NanoGenotoxicology: present and the future

Sensitive detection of DNA oxidation damage induced by nanomaterials

Organisation of a Kick-Off Meeting (All Participants, EC)

Document on the feasibility to come to organized pre-regulatory safety dossiers

Final Standardisation plan

Progress review reports by industrial technical advisors on the overall progress of the project and on progress within e...

perspectives on how regulations can keep pace with innovation (paper)

Document describing a blueprint for the creation of trusted environments per stage gate to share information among stake...

Report on integrated safety assessment framework

Overview of barriers and possible solutions for implementation of the Safe Innovations Approach

Usefulness of fish cell lines for the initial characterization of toxicity and cellular fate of graphene-related materia...

Drug Delivery Nanosystems for Cardiovascular Stents

Toxicity evaluation of monodisperse PEGylated magnetic nanoparticles for nanomedicine

Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation

Implementation of Safe-by-Design for Nanomaterial Development and Safe Innovation: Why We Need a Comprehensive Approach

Nanomedicine and epigenome. Possible health risks

Implementation manual of the Safe Innovations Approach for all users

NANoREG II website

Towards the development of a high throughput screening approach for Mytilus edulis hemocytes: A case study on silicon-ba...

Refining in vitro models for nanomaterial exposure to cells and tissues

Fate modelling of nanoparticle releases in LCA: An integrative approach towards “USEtox4Nano”

Investigating a transcriptomic approach on marine mussel hemocytes exposed to carbon nanofibers: An in vitro/in vivo com...

In Vitro Approaches for Assessing the Genotoxicity of Nanomaterials

Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?